載入...
Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong
BACKGROUND: Dabigatran is an oral direct thrombin inhibitor recently approved for stroke prevention in atrial fibrillation (AF) as an alternative to warfarin. The primary advantages of dabigatran are freedom from monitoring and less interaction with other drugs and food. It is ideal for patients who...
Na minha lista:
| 發表在: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wiley Periodicals, Inc.
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652425/ https://ncbi.nlm.nih.gov/pubmed/23108916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22069 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|